.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Accenture
Farmers Insurance
Chubb
US Department of Justice
Dow
Federal Trade Commission
US Army
Fish and Richardson
McKesson

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074311

« Back to Dashboard
NDA 074311 describes TRIFLURIDINE, which is a drug marketed by Sandoz Inc and is included in one NDA. It is available from one supplier. Additional details are available on the TRIFLURIDINE profile page.

The generic ingredient in TRIFLURIDINE is trifluridine. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the trifluridine profile page.

Summary for NDA: 074311

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Pharmacology for NDA: 074311

Ingredient-typeNucleoside Analog
Mechanism of ActionNucleic Acid Synthesis Inhibitors

Suppliers and Packaging for NDA: 074311

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIFLURIDINE
trifluridine
SOLUTION/DROPS;OPHTHALMIC 074311 ANDA Falcon Pharmaceuticals, Ltd. 61314-044 61314-044-75 7.5 mL in 1 BOTTLE, PLASTIC (61314-044-75)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength1%
Approval Date:Oct 6, 1995TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Harvard Business School
Cipla
Moodys
Fuji
UBS
Queensland Health
Argus Health
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot